Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Notes Payables (2016 - 2020)

Historic Notes Payables for Fresenius Medical Care AG (FMS) over the last 12 years, with Q3 2020 value amounting to $358.6 million.

  • Fresenius Medical Care AG's Notes Payables fell 7941.72% to $358.6 million in Q3 2020 from the same period last year, while for Sep 2020 it was $358.6 million, marking a year-over-year decrease of 7941.72%. This contributed to the annual value of $1.3 billion for FY2019, which is 954.78% down from last year.
  • Fresenius Medical Care AG's Notes Payables amounted to $358.6 million in Q3 2020, which was down 7941.72% from $964.5 million recorded in Q2 2020.
  • Over the past 5 years, Fresenius Medical Care AG's Notes Payables peaked at $1.7 billion during Q3 2019, and registered a low of $895177.3 during Q4 2017.
  • Moreover, its 5-year median value for Notes Payables was $1.1 billion (2017), whereas its average is $989.2 million.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Notes Payables plummeted by 9985.51% in 2017, and later soared by 15358108.64% in 2018.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Notes Payables stood at $617.6 million in 2016, then tumbled by 99.86% to $895177.3 in 2017, then surged by 153581.09% to $1.4 billion in 2018, then fell by 7.47% to $1.3 billion in 2019, then tumbled by 71.83% to $358.6 million in 2020.
  • Its last three reported values are $358.6 million in Q3 2020, $964.5 million for Q2 2020, and $1.7 billion during Q1 2020.